Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2α
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 20 (3), 416-420
- https://doi.org/10.1016/s0168-8278(94)80018-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Neutralizing Antibodies to Interferon- : Relative Frequency in Patients Treated with Different Interferon PreparationsThe Journal of Infectious Diseases, 1991
- Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trialJournal of Hepatology, 1990
- The biological basis for clinical use of interferonJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis.BMJ, 1989
- A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus AntibodiesScandinavian Journal of Infectious Diseases, 1989
- Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon AntibodiesNew England Journal of Medicine, 1988
- Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injectionCancer, 1987
- The detection of antibodies to recombinant interferon alfa-2a in human serumJournal of Biological Standardization, 1987